Business
Coronavirus vaccine: Oxford, AstraZeneca resume trial after patient’s serious side-effect – PerthNow
Days after a vaccine trial was suspended following a reported side-effect in a UK patient, Oxford University has announced the study will resume.
Oxford University has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.
In a statement on Saturday, the university confirmed the restart across all of its UK clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The independent review process has concluded and following the recommendations of…
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News22 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’
-
Business19 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?